An open-label study of Xeloda [capecitabine] plus gemcitabine on tumor response in patients with locally advanced or metastatic pancreatic cancer
Latest Information Update: 08 Oct 2015
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Roche
- 22 Jul 2008 Status changed from in progress to completed, as reported by Roche.
- 01 Jun 2006 New trial record.